Glioma Patients Clinical Trial
Official title:
Hypertension Monitoring in Glioma Patients Treated With Bevacizumab
Prospective casecontrol study in glioma patients undergoing treatment with bevacizumab
(Avastin). At present there are no data on the correlation between occurrence of arterial
hypertension and clinical outcome in patients with glioma or anaplastic astrocytoma. We will
investigate whether glioma patients developing hypertension under bevacizumab treatment have
a better outcome in terms of progression free survival, response rate and overall survival
than equally treated patients remaining normotensive. Moreover, we will describe the
dynamics of change in blood pressure after administration of bevacizumab in those patients
developing hypertension.
- Trial with medicinal product
n/a
Time Perspective: Prospective